- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07724184
Revascularization of Calcified Coronary Arteries (PICA)
July 22, 2026 updated by: Ashkan Eftekhari, Aalborg University Hospital
Percutaneous Coronary Intervention of Calcified Lesions and the Use of Artificial Intelligence to Predict Successful Outcome
The primary aim of this study is to evaluate changes in absolute coronary flow and pressure before and after percutaneous coronary intervention in calcified lesions.
The secondary aim is to use a machine learning model to predict the outcome of the intervention.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ashkan Eftekhari, MD PhD
- Phone Number: +4597664465
- Email: asef@rn.dk
Study Locations
-
-
-
Aalborg, Denmark
- Recruiting
- Aalborg University Hospital
-
Contact:
- Julie Juul Siig, MD
- Phone Number: +45 97 66 00 00
- Email: j.dyhr@rn.dk
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
This a prospective clinical cohort study recruiting patients with stable coronary artery disease referred to invasive coronary angiography on clinical indication with angiographic calcium and eligible for PCI.
Description
Inclusion Criteria:
- Age > 18 years
- Moderate (40-90 %) epicardial disease
- Vessel suitable for PCI and intracoronary imaging
- De novo-lesions
Exclusion Criteria:
- eGFR < 40ml/min
- ACS < 48 hours
- Patient without ability to provide informed consent
- Patient with left main stenosis
- Indication for coronary artery bypass grafting
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Post-PCI FFR
Time Frame: Immediately after the procedure
|
FFR is measured after PCI is completed.
|
Immediately after the procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2025
Primary Completion (Estimated)
May 1, 2027
Study Completion (Estimated)
May 1, 2030
Study Registration Dates
First Submitted
August 20, 2025
First Submitted That Met QC Criteria
July 22, 2026
First Posted (Actual)
July 23, 2026
Study Record Updates
Last Update Posted (Actual)
July 23, 2026
Last Update Submitted That Met QC Criteria
July 22, 2026
Last Verified
July 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 113255
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.